PMID- 18246698 OWN - NLM STAT- MEDLINE DCOM- 20080505 LR - 20151119 IS - 1545-9616 (Print) IS - 1545-9616 (Linking) VI - 7 IP - 1 DP - 2008 Jan TI - Primary cutaneous Cryptococcosis during therapy with methotrexate and adalimumab. PG - 53-4 AB - Primary cutaneous infection with Cryptococcus neoformans is uncommon, but can occur following an inoculation injury to the skin. Tumor necrosis factor-alpha (TNF-alpha) is important in the immune response to Cryptococcus, and patients taking inhibitors of TNF-alpha may have increased susceptibility to cryptococcal infection. We report a case of primary cutaneous cryptococcosis in a patient taking adalimumab, methotrexate, and hydroxychloroquine for rheumatoid arthritis. FAU - Wilson, Morgan L AU - Wilson ML AD - Geisinger Medical Center, Department of Dermatology, Danville, PA 17822, USA. mlwilson@geisinger.edu FAU - Sewell, Lindsay D AU - Sewell LD FAU - Mowad, Christen M AU - Mowad CM LA - eng PT - Case Reports PT - Journal Article PL - United States TA - J Drugs Dermatol JT - Journal of drugs in dermatology : JDD JID - 101160020 RN - 0 (Antibodies, Monoclonal) RN - 0 (Antibodies, Monoclonal, Humanized) RN - 0 (Antifungal Agents) RN - 0 (Antirheumatic Agents) RN - 4QWG6N8QKH (Hydroxychloroquine) RN - 8VZV102JFY (Fluconazole) RN - FYS6T7F842 (Adalimumab) RN - YL5FZ2Y5U1 (Methotrexate) SB - IM MH - Adalimumab MH - Antibodies, Monoclonal/*therapeutic use MH - Antibodies, Monoclonal, Humanized MH - Antifungal Agents/therapeutic use MH - Antirheumatic Agents/therapeutic use MH - Arthritis, Rheumatoid/complications/drug therapy MH - Cryptococcosis/complications/*diagnosis/drug therapy MH - Cryptococcus neoformans/drug effects/growth & development/isolation & purification MH - Dermatomycoses/complications/*diagnosis/drug therapy MH - Female MH - Finger Injuries/complications/diagnosis/microbiology MH - Fluconazole/therapeutic use MH - Humans MH - Hydroxychloroquine/therapeutic use MH - Methotrexate/*therapeutic use MH - Middle Aged EDAT- 2008/02/06 09:00 MHDA- 2008/05/06 09:00 CRDT- 2008/02/06 09:00 PHST- 2008/02/06 09:00 [pubmed] PHST- 2008/05/06 09:00 [medline] PHST- 2008/02/06 09:00 [entrez] PST - ppublish SO - J Drugs Dermatol. 2008 Jan;7(1):53-4.